Investing.com -- A federal judge has blocked the Trump administration from proceeding with plans to restructure the U.S.

Investing.com -- INmune Bio (NASDAQ: INMB) shares fell another 6% to about $2.17 on Tuesday after brokerages downgraded the stock, saying failure of the company’s experimental Alzheimer’s drug XPro in ...